LAKE FOREST, Calif., Aug. 13, 2019 /PRNewswire/ -- International Pop Icon Paula Abdul has made her mark in this industry as an award-winning dancer and choreographer, singer, actress, and television personality with six number-one singles on the Billboard Hot 100, Emmy and Grammy Awards, and numerous other accolades. Paula has agreed to join InMode Ltd. (Nasdaq: INMD) ("

CHICAGO, Aug. 13, 2019 /PRNewswire/ -- Apervita, the leading platform for performance-based collaboration in healthcare, today announced the acquisition of Boston-based Qcentive, a leader in value-based contract and alternative payment administration solutions for healthcare organizations. The combined Apervita-Qcentive solutions wil

KANSAS CITY, Mo., Aug. 13, 2019 /PRNewswire/ -- CRB is excited to announce the promotion of Ben Skowronski to the leader of the Maryland office.

Anticipates net revenue of approximately $19 million and positive Adjusted EBITDA1 for Q4 2019. Forecasts net revenue for fiscal 2020 to be between $150 million and $180 million, and positive Adjusted EBITDA1 for fiscal 2020. The Company will not pursue potential share consolidation appro

WEST DES MOINES, Iowa, Aug. 13, 2019 /PRNewswire/ -- CHC Health, announced today that former Humana/CVS Health executive, Andy Papa, has joined their C-suite management team as the Chief Revenue Officer.  Andy will lead business development, marketing and sales strategies across the spectrum of CHC Health's lines of business.  In

MANHASSET, N.Y., Aug. 13, 2019 /PRNewswire/ -- Feinstein Institutes for Medical Research scientists are the first to publish clinical trial results of an inv

Company continues to expand its portfolio of highly selective antibodies targeting root cause of Alzheimer's, ALS and Parkinson's disease TORONTO and CAMBRIDGE, MA, Aug. 13, 2019 /PRNewswire/ - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and developm

HOUSTON, Aug. 13, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced its proof of concept clinical trial to evaluate its p-STAT3 inhibitor, WP1220, for the topical treatment of Cutaneous T-Cell

BETHESDA, Md., Aug. 13, 2019 /PRNewswire/ -- Healthy Directions LLC, a subsidiary of Adaptive Health, LLC, is proud to announce its corporate sponsorship of Vitamin Angels, a global public health nonprofit that distributes lifesaving vitamins and minerals to women and children in need around the world.

MONMOUTH JUNCTION, N.J., Aug. 13, 2019 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its